1331560-65-6 Usage
General Description
The chemical compound (3E)-4-(3-Bromo-4-Methoxyphenyl)but-3-en-2-one is an organic compound with a molecular formula C11H11BrO2. It is a ketone with a butenone backbone featuring a bromo-methoxy-substituted phenyl group. (3E)-4-(3-BroMo-4-Methoxyphenyl)but-3-en-2-one is often used in organic synthesis and pharmaceutical research due to its unique structure and potential for use as a building block in the production of biologically active compounds. It is important to handle this compound with care and follow proper safety protocols, as it may pose health and environmental hazards if mishandled.
Check Digit Verification of cas no
The CAS Registry Mumber 1331560-65-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,1,5,6 and 0 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1331560-65:
(9*1)+(8*3)+(7*3)+(6*1)+(5*5)+(4*6)+(3*0)+(2*6)+(1*5)=126
126 % 10 = 6
So 1331560-65-6 is a valid CAS Registry Number.
1331560-65-6Relevant articles and documents
Synthesis and biological activity of novel tiliroside derivants
Qin, Nan,Li, Chun-Bao,Jin, Mei-Na,Shi, Li-Huan,Duan, Hong-Quan,Niu, Wen-Yan
scheme or table, p. 5189 - 5195 (2011/11/14)
A series of new tiliroside derivatives were synthesized and characterized by analytical 1H NMR, 13C NMR and mass spectrometry. All of the compounds were evaluated for anti-diabetic properties in vitro using HepG2 cells. Compounds 3c, 3d, and 3i-l caused significant enhancements in glucose consumption by insulin-resistant HepG2 cells compared with control cells and cells that were exposed to metformin (an anti-diabetic drug). Moreover, compound 3l significantly activated adenosine 5′-monophosphate-activated protein kinase activity and reduced acetyl-CoA carboxylase activity. Thus, the tiliroside derivative 3l offers potential to be developed as a new approach for treating type II diabetes.
